CRISPR-GPT, a large language model developed at Stanford Medicine, is accelerating gene-editing processes and increasing accessibility to CRISPR.

The Alliance for Clinical Trials in Oncology will host a public webinar on Monday, September 29, at 12 pm CT showcasing the key findings of Alliance research presented at the 2025 American Society for Clinical Oncology (ASCO) Annual Meeting. The clinical trial results discussed at the virtual meeting will include some of the latest information for people living with colorectal, squamous cell, and renal cell cancers.  

Abbreviated, 15- to 30-minute medication visits have become common in psychiatry now that many insurers model their reimbursement patterns on internal medicine and surgery. To support practicing psychiatrists, a series of four columns in the Journal of Psychiatric Practice®, part of the Lippincott portfolio from Wolters Kluwer, describe how to feasibly combine brief psychotherapy with longitudinal pharmacotherapy. The final installment appears in the September issue.

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world’s most pressing health challenges. By combining advanced computer modeling with real-world patient data, the team has created "virtual clinical trials" that may facilitate the discovery of effective therapies while reducing the time, cost, and risk of failed studies.

The global prevalence of AD is projected to triple by 2050 and currently there are limited strategies to prevent or slow down the progression of this devastating condition. Physical exercise is known to reduce the risk or slow the progression of Alzheimer’s disease (AD). At Baylor College of Medicine researchers investigated the underlying mechanisms that mediate the effects of exercise on AD, as this might provide new ways to treat the condition.

The Brain & Behavior Research Foundation is hosting its 2025 International Mental Health Research Symposium on Friday, October 24, from 9:30am to 12:30pm EDT, at the Kaufman Music Center, 129 West 67th Street (between Broadway & Amsterdam) in Manhattan. This free, public event will feature leading scientists presenting their latest research on ADHD, schizophrenia, bipolar disorder, advocacy and more.